Videos
The Importance of Biomarker Testing for Patients With NSCLC
01/05/2023
Edward Garon, MD, David Geffen School of Medicine, University of California – Los Angeles, and Lyudmila Bazhenova, MD, University of California – San Diego, discuss their approaches to biomarker testing for patients newly diagnosed with non-small cell lung cancer (NSCLC), the role of tissue vs liquid biopsy, and how these biomarkers are used to inform treatment decisions.
Watch part 1 where Dr Garon and Dr Bazhenova discuss options for frontline management of NSCLC.